Performance After Cochlear Reimplantation Using a Different Manufacturer.

IF 1.9 3区 医学 Q3 CLINICAL NEUROLOGY Otology & Neurotology Pub Date : 2024-10-01 DOI:10.1097/mao.0000000000004314
Justin Cottrell,Emily Spitzer,Arianna Winchester,Camille Dunn-Johnson,Bruce Gantz,Susan Rathgeb,Matthew Shew,Jacques Herzog,Craig Buchman,David Friedmann,Daniel Jethanamest,Sean McMenomey,Susan Waltzman,J Thomas Roland
{"title":"Performance After Cochlear Reimplantation Using a Different Manufacturer.","authors":"Justin Cottrell,Emily Spitzer,Arianna Winchester,Camille Dunn-Johnson,Bruce Gantz,Susan Rathgeb,Matthew Shew,Jacques Herzog,Craig Buchman,David Friedmann,Daniel Jethanamest,Sean McMenomey,Susan Waltzman,J Thomas Roland","doi":"10.1097/mao.0000000000004314","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\nTo better understand cochlear implant (CI) performance after reimplantation with a different device manufacturer.\r\n\r\nSTUDY DESIGN\r\nMultisite retrospective review.\r\n\r\nSETTING\r\nTertiary referral centers.\r\n\r\nPATIENTS\r\nPatients older than 4 years who received a CI and subsequently underwent CI reimplantation with a different manufacturer over a 20-year period.\r\n\r\nINTERVENTION\r\nReimplantation.\r\n\r\nMAIN OUTCOME MEASURE\r\nThe primary outcome was difference in the best CNC score obtained with the primary CI, compared with the most recent CNC score obtained after reimplantation.\r\n\r\nRESULTS\r\nTwenty-nine patients met the criteria at three centers. The best average CNC score achieved by adult patients after primary cochlear implantation was 46.2% (n = 16), measured an average of 14 months (range: 3-36 mo) postoperatively. When looking at the most recent CNC score of adult patients before undergoing reimplantation, the average CNC score dropped to 19.2% (n = 17). After reimplantation, the average 3- to 6-month CNC score was 48.3% (n = 12), with most recent average CNC score being 44.4% (n = 17) measured an average of 19 months (range: 3-46 mo) postoperatively. There was no statistically significant difference (p = 0.321; t11 = 0.48) identified in performance between the best CNC score achieved by adult patients after primary cochlear implantation, and the most recent score achieved after reimplantation (n = 12). Analysis of prerevision and postrevision speech performance was not possible in pediatric patients (<18 yr old) because of differences in tests administered.\r\n\r\nCONCLUSION\r\nPatients undergoing reimplantation with a different manufacturer achieved CNC score performance comparable to their best performance with their original device.","PeriodicalId":19732,"journal":{"name":"Otology & Neurotology","volume":"65 1","pages":"1016-1022"},"PeriodicalIF":1.9000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Otology & Neurotology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/mao.0000000000004314","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

OBJECTIVE To better understand cochlear implant (CI) performance after reimplantation with a different device manufacturer. STUDY DESIGN Multisite retrospective review. SETTING Tertiary referral centers. PATIENTS Patients older than 4 years who received a CI and subsequently underwent CI reimplantation with a different manufacturer over a 20-year period. INTERVENTION Reimplantation. MAIN OUTCOME MEASURE The primary outcome was difference in the best CNC score obtained with the primary CI, compared with the most recent CNC score obtained after reimplantation. RESULTS Twenty-nine patients met the criteria at three centers. The best average CNC score achieved by adult patients after primary cochlear implantation was 46.2% (n = 16), measured an average of 14 months (range: 3-36 mo) postoperatively. When looking at the most recent CNC score of adult patients before undergoing reimplantation, the average CNC score dropped to 19.2% (n = 17). After reimplantation, the average 3- to 6-month CNC score was 48.3% (n = 12), with most recent average CNC score being 44.4% (n = 17) measured an average of 19 months (range: 3-46 mo) postoperatively. There was no statistically significant difference (p = 0.321; t11 = 0.48) identified in performance between the best CNC score achieved by adult patients after primary cochlear implantation, and the most recent score achieved after reimplantation (n = 12). Analysis of prerevision and postrevision speech performance was not possible in pediatric patients (<18 yr old) because of differences in tests administered. CONCLUSION Patients undergoing reimplantation with a different manufacturer achieved CNC score performance comparable to their best performance with their original device.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用不同制造商的人工耳蜗再植入术后的表现
目的:更好地了解不同设备制造商再植入人工耳蜗 (CI) 后的性能。主要结果测量主要结果是使用主要 CI 获得的最佳 CNC 分数与重新植入后获得的最新 CNC 分数的差异。结果三个中心的 29 名患者符合标准。成年患者在初次人工耳蜗植入术后获得的最佳平均 CNC 分数为 46.2%(n = 16),平均测量时间为术后 14 个月(范围:3-36 个月)。再植入前,如果查看成年患者最近的 CNC 得分,平均 CNC 得分降至 19.2%(n = 17)。再植后,3-6 个月的平均 CNC 得分为 48.3%(12 人),最近的平均 CNC 得分为 44.4%(17 人),平均测量时间为术后 19 个月(3-46 个月)。成年患者在初次人工耳蜗植入术后获得的最佳 CNC 分数与再植入术后获得的最新分数(n = 12)之间没有发现明显的统计学差异(p = 0.321;t11 = 0.48)。由于所做测试的不同,无法对儿童患者(18 岁以下)的术前和术后言语表现进行分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Otology & Neurotology
Otology & Neurotology 医学-耳鼻喉科学
CiteScore
3.80
自引率
14.30%
发文量
509
审稿时长
3-6 weeks
期刊介绍: ​​​​​Otology & Neurotology publishes original articles relating to both clinical and basic science aspects of otology, neurotology, and cranial base surgery. As the foremost journal in its field, it has become the favored place for publishing the best of new science relating to the human ear and its diseases. The broadly international character of its contributing authors, editorial board, and readership provides the Journal its decidedly global perspective.
期刊最新文献
Impact of Perioperative Anticoagulation and Antiplatelet Therapy on Hearing Preservation Outcomes. Angiotensin-Receptor Blockers Prevent Vestibular Schwannoma-Associated Hearing Loss. Detection of Extracochlear Electrodes Using Electrical Field Imaging (EFI). Preclinical Study of a Minimally Invasive Cochlear Implant Device Based on 3D Printing of a Custom Guide. Long-Term Clinical Outcomes for Bone-Anchored Hearing Implants: 3-Year Comparison Between Minimally Invasive Ponto Surgery and the Linear Incision Technique With Tissue Preservation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1